1. Home
  2. BTG vs STVN Comparison

BTG vs STVN Comparison

Compare BTG & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B2Gold Corp

BTG

B2Gold Corp

HOLD

Current Price

$5.11

Market Cap

6.9B

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.32

Market Cap

5.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTG
STVN
Founded
2006
1949
Country
Canada
Italy
Employees
N/A
N/A
Industry
Precious Metals
Containers/Packaging
Sector
Basic Materials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
5.7B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
BTG
STVN
Price
$5.11
$19.32
Analyst Decision
Buy
Buy
Analyst Count
13
14
Target Price
$6.45
★ $24.47
AVG Volume (30 Days)
★ 17.7M
311.0K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 1.60%
0.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.66
$7.05
Revenue Next Year
$18.24
$9.23
P/E Ratio
$34.75
★ $27.15
Revenue Growth
N/A
N/A
52 Week Low
$3.57
$12.89
52 Week High
$6.29
$27.99

Technical Indicators

Market Signals
Indicator
BTG
STVN
Relative Strength Index (RSI) 45.93 33.12
Support Level $5.08 $18.87
Resistance Level $5.68 $19.70
Average True Range (ATR) 0.18 0.85
MACD -0.05 -0.26
Stochastic Oscillator 22.78 10.46

Price Performance

Historical Comparison
BTG
STVN

About BTG B2Gold Corp

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: